Trial NCT04962906; NCT05027672
Publication Macchia A, Lancet Reg Health Am, 2022
Primary outcome on the report: Geometric mean concentration ratio (SARS-CoV-2 anti-spike IgG) at 28 days

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.